Treatment paradigms in undifferentiated pleomorphic sarcoma of bone: lessons learned from osteosarcoma and questions that remain commentary on: Bielack SS et al. J Cancer Res Clin Oncol (2026)
Journal of Cancer Research and Clinical Oncology · 24.03.2026 · 152 (3)
DOI: 10.1007/s00432-026-06456-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 24.03.2026. Verfasst von Aslı Geçgel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Yozgat City Hospital, 66100, Yozgat, Turkey. dr.asltrgt@gmail.com. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
interest the large multicenter study by Bielack and colleagues, based on the Cooperative Osteo-sarcoma Study Group (COSS) database, which provides comprehensive real-world evidence on outcomes achieved with osteosarcoma-based treatment strategies in undifferen - tiated pleomorphic sarcoma of bone (UPSB) (Bielack et al. 2026). UPSB is a rare malignant bone tumor that, owing to diagnostic challenges and the scarcity of prospective data, has traditionally been managed according to treatment principles established for osteosarcoma (Beird et al. 2022, Strauss et al. 2021). Encompassing 132 patients treated over four decades, this cohort constitutes one of the largest and most mature datasets reported for UPSB to date (Bielack et al. 2026). One of the most striking findings of the study is the clear demographic distinction between UPSB and osteosarcoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Yozgat City Hospital, 66100, Yozgat, Turkey. dr.asltrgt@gmail.com.
- Department of Medical Oncology, Adana City Hospital, 01370, Adana, Turkey.
Zitieren
APA
Geçgel, A., & Peker, P. (2026). Treatment paradigms in undifferentiated pleomorphic sarcoma of bone: lessons learned from osteosarcoma and questions that remain commentary on: Bielack SS et al. J Cancer Res Clin Oncol (2026). Journal of Cancer Research and Clinical Oncology, 152(3). https://doi.org/10.1007/s00432-026-06456-2
Vancouver
Geçgel A, Peker P. Treatment paradigms in undifferentiated pleomorphic sarcoma of bone: lessons learned from osteosarcoma and questions that remain commentary on: Bielack SS et al. J Cancer Res Clin Oncol (2026). Journal of Cancer Research and Clinical Oncology. 2026;152(3). doi:10.1007/s00432-026-06456-2
BibTeX
@article{Gegel2026,
author = {Geçgel, Aslı and Peker, Pınar},
title = {Treatment paradigms in undifferentiated pleomorphic sarcoma of bone: lessons learned from osteosarcoma and questions that remain commentary on: Bielack SS et al. J Cancer Res Clin Oncol (2026)},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2026},
volume = {152},
number = {3},
doi = {10.1007/s00432-026-06456-2}
}
EUVIMED